GenScript USA Inc. – a subsidiary of GenScript Biotech Corp. headquartered in Piscataway – announced May 26 it reached an agreement with Euroimmun US Inc. – a Euroimmun subsidiary based in Mountain ...
NANJING, China and SAN DIEGO, June 2, 2021 /PRNewswire/ -- GenScript Biotech Corporation (HKG: 1548) along with its subsidiary, GenScript ProBio, and Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) ...
GenScript ProBio is the subsidiary of GenScript Biotech Corp. (HK.1548), building upon GenScript’s solid gene synthesis technology and deep expertise in the antibody, cell, and gene therapy fields, ...
GenScript Biotech provides life science research services and products, and is well known for its gene synthesis capabilities. Its business can roughly be divided into non-cell therapy, or NCT, ...
PISCATAWAY, N.J. & NEW YORK--(BUSINESS WIRE)--GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy ...
Hello, and welcome to the GenScript Biotech Interim 2023 Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. It is now my pleasure to ...
NANJING, China, Jan. 15, 2020 /PRNewswire/ -- On January 14, 2020, at San Francisco, USA, a global leading biotech company GenScript announced that it signed a strategic partnership agreement for the ...
AstraZeneca and Daiichi Sankyo are looking at moving their antibody-drug conjugate Enhertu into another new breast cancer patient class. Ahead of the American Society of Clinical Oncology annual ...
NANJING, China, Aug. 31, 2022 /PRNewswire/ -- GenScript Biotech, the world's leading biotech company, today announces its annual results as of June 30, 2022. "In the first half of 2022, GenScript ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback